BGC > Produktsuche > N-(2-(Diethylamino)ethyl)-5-((Z)-(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl)-2,4-dimethyl-1H-pyrrole-3-carboxamide (2S)-hydroxybutanedioate | 341031-54-7

Molecular Formula: C22H27FN4O2.C4H6O5
Molecular Weight: 532.566
Hazard Symbols: T
WGKGermany: 2
HS Code: 29337900

Assay:99.0%min

Description:
Sunitinib (marketed as Sutent by Pfizer, and previously known as SU11248) is an oral, small-molecule, multi-targeted receptor tyrosine kinase (RTK) inhibitor that was approved by the FDA for the treatment of renal cell carcinoma (RCC) and imatinib-resistant gastrointestinal stromal tumor (GIST) on January 26, 2006. Sunitinib was the first cancer drug simultaneously approved for two different indications.

• Molecular Weight:532.56
• Melting Point:187-191°C
• Purity:>98%

Molecular Formula:
C22H27FN4O2.C4H6O5
Canonical SMILES:
CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C.C(C(C(=O)O)O)C(=O)O
InChI:
InChI=1S/C22H27FN4O2.C4H6O5/c1-5-27(6-2)10-9-24-22(29)20-13(3)19(25-14(20)4)12-17-16-11-15(23)7-8-18(16)26-21(17)28;5-2(4(8)9)1-3(6)7/h7-8,11-12,25H,5-6,9-10H2,1-4H3,(H,24,29)(H,26,28);2,5H,1H2,(H,6,7)(H,8,9)/b17-12-;/t;2-/m.0/s1
InChIKey:
LBWFXVZLPYTWQI-IPOVEDGCSA-N
Appearance:
Yellow to Orange Solid
Application:
Angiogenesis Inhibitors
Synonyms:
Sunitinib malate; SU011248 L-malate salt; N-[2-(diethylamino)ethyl]-5-[(Z)-(5-fluoro-2-oxo-1H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide;(2S)-2-hydroxybutanedioic acid

Purity: 98%
Smile code: O=C(C1=C(C)NC(/C=C2C(NC3=C2C=C(F)C=C3)=O)=C1C)NCCN(CC)CC.O=C(O)[C@@H](O)CC(O)=O
MDL Number: MFCD08282795
MolFormula: C26H33FN4O7
MolWeight: 532.5612
Available in stock: 222.092

Smile code:
O=C(C1=C(C)NC(/C=C2C(NC3=C2C=C(F)C=C3)=O)=C1C)NCCN(CC)CC.O=C(O)[C@@H](O)CC(O)=O
MDL Number:
MFCD08282795
Purity :
98%
Available in stock:
170.165 g